Skip to main content

Table 2 Baseline characteristics

From: Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results

Parameter Placebo (n = 20) ASC (n = 40) P-value
Age (years) 65.3 ± 8.7 65.5 ± 9.7 0.94
Male gender 20 (100) 35 (87.5) 0.02
BMI (kg/m2) 30.0 ± 4.8 30.0 ± 4.1 0.92
Smoking 0.19
 Current 3 (15) 8 (20)  
 Previous 16 (80) 23 (57.5)  
 Never 1 (5) 9 (22.5)  
Diabetes mellitus 6 (30) 16 (40) 0.57
Hypertension 12 (60) 33 (82.5) 0.06
Previous AMI 10 (50) 26 (65) 0.26
Previous CABG 20 (100) 33 (82.5) 0.08
Previous PCI 15 (75) 28 (70) 0.69
LVEF (%) 54 ± 8 52 ± 8 0.38
  1. AMI acute myocardial infarction, ASC adipose-derived stromal cell, BMI body mass index, CABG coronary artery bypass grafting, LVEF left ventricular ejection fraction, n number of patients, PCI percutaneous coronary intervention